Pharmaceutical Quality Management Systems Market Analysis

Pharmaceutical Quality Management Systems Market Analysis

To get key market trends

  Download Free Sample

Based on deployment model, the pharmaceutical quality management systems market is segmented into cloud-based and on-premise. The cloud-based segment is expected to register around USD 2 billion by 2032. The cloud-based deployment model provides considerable advantages compared to traditional on-premises software or paper-based systems. The cloud-based technology simplifies the transition to an electronic QMS and enables remote access within a highly secure environment. Additionally, the model offers easy scalability, allowing businesses to increase the number of users and storage in response to changing business requirements.
 

Based on enterprise size, the pharmaceutical quality management systems market is segmented into large enterprise and small & medium enterprise (SME). The large enterprise segment accounted for 62% of the market share in 2022. Extensive operations, complex supply chains, and stringent compliance requirements in large enterprises will contribute to the industry gains. Furthermore, large enterprises often operate globally, making it crucial to have comprehensive quality management systems in place to ensure compliance across multiple jurisdictions.
 

North America pharmaceutical quality management systems market accounted for 42.3% market share in 2022. The region's well-established pharmaceutical industry, rigorous regulatory framework, and emphasis on quality standards will drive the demand for pharmaceutical quality management systems. For instance, in January 2021, Arena Solutions, Inc. partnered with Rimsys Inc., a developer of regulatory information management (RIM) software platforms to offer an end-to-end quality and product-centric regulatory solution. This partnership helped the company to expand its product offering.